DCGO · Docgo Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $75.55M | - | $70.81M | $80.42M | $96.03M | - | $138.68M | $164.95M | $192.09M | - |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| R&D | $3.71M | - | $3.19M | $2.96M | $3.64M | - | $3.15M | $2.37M | $2.39M | - |
| SG&A | $30.84M | - | $30.09M | $31.24M | $32.90M | - | $28.78M | $34.75M | $40.18M | - |
| Total Operating Expenses | $94.26M | - | $112.79M | $97.90M | $110.03M | - | $128.55M | $154.80M | $176.21M | - |
| D&A | $2.65M | - | $3.97M | $3.98M | $3.76M | - | $4.18M | $4.20M | $1.43M | - |
| Operating Income | ($18.71M) | - | ($41.98M) | ($17.48M) | ($14.00M) | - | $10.14M | $10.15M | $15.88M | - |
| Interest Expense | - | - | - | - | - | - | - | - | - | - |
| Income Tax | $19.3K | - | ($13.51M) | ($4.63M) | ($3.72M) | - | $4.49M | $3.71M | $5.12M | - |
| Net Income | ($14.76M) | - | $5.50M | $6.53M | ($9.41M) | - | $5.50M | $6.53M | $11.23M | - |
| EPS - Basic | ($0.15) | - | ($0.28) | ($0.11) | ($0.09) | - | $0.05 | $0.06 | $0.11 | - |
| EPS - Diluted | ($0.15) | - | ($0.28) | ($0.11) | ($0.09) | - | $0.05 | $0.06 | $0.10 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $35.68M | $51.02M | $73.36M | $104.16M | $79.01M | $89.24M | $89.46M | $66.06M | $41.24M | $59.29M |
| Accounts Receivable | $93.97M | $92.89M | $107.02M | $122.76M | $178.76M | $210.90M | $233.71M | $257.50M | $283.13M | $262.08M |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | $13.87M | $11.11M | $8.05M | $10.12M | $20.52M | $28.36M | $35.14M | $30.80M | $25.63M | $19.83M |
| Current Assets | $138.17M | $152.40M | $190.23M | $236.57M | $262.53M | $304.49M | $328.33M | $328.71M | $335.13M | $338.87M |
| Total Assets | $209.23M | $217.10M | $353.78M | $408.26M | $430.79M | $455.62M | $493.88M | $488.17M | $490.69M | $490.45M |
| Current Liabilities | $77.22M | $67.49M | $73.58M | $100.15M | $107.57M | $121.81M | $150.23M | $154.12M | $160.14M | $170.12M |
| Long-term Debt | $171.7K | $183.8K | $195.7K | $0 | $2.2K | $5.2K | $21.3K | $27.3K | $33.7K | $41.6K |
| Total Liabilities | $98.02M | $91.23M | $93.12M | $120.53M | $128.87M | $140.44M | $168.98M | $170.18M | $175.61M | $185.28M |
| Stockholders' Equity | $132.31M | $144.01M | $270.53M | $297.28M | $309.34M | $320.92M | $325.21M | $315.16M | $311.32M | $300.79M |
| Retained Earnings | ($198.56M) | ($183.80M) | ($49.73M) | ($21.96M) | ($10.81M) | ($1.40M) | $1.86M | ($3.64M) | ($10.17M) | ($21.39M) |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($4.66M) | - | - | - | $9.66M | - | - | - | ($10.64M) | - |
| Investing Cash Flow | $1.66M | - | - | - | ($5.73M) | - | - | - | ($1.70M) | - |
| Financing Cash Flow | ($2.46M) | - | - | - | ($8.52M) | - | - | - | ($881.6K) | - |
| CapEx | $430.3K | - | - | - | $1.47M | - | $4.23M | $4.82M | $951.7K | - |
| Free Cash Flow | ($5.09M) | - | - | - | $8.19M | - | - | - | ($11.59M) | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | -24.8% | - | -59.3% | -21.7% | -14.6% | - | 7.3% | 6.2% | 8.3% | - |
| EBITDA margin | -21.3% | - | -53.7% | -16.8% | -10.7% | - | 10.3% | 8.7% | 9.0% | - |
| Net margin | -19.5% | - | 7.8% | 8.1% | -9.8% | - | 4.0% | 4.0% | 5.8% | - |
| Free cash flow margin | -6.7% | - | - | - | 8.5% | - | - | - | -6.0% | - |
| FCF / Net income | 0.34 | - | - | - | -0.87 | - | - | - | -1.03 | - |
| R&D / Revenue | 4.9% | - | 4.5% | 3.7% | 3.8% | - | 2.3% | 1.4% | 1.2% | - |
| SG&A / Revenue | 40.8% | - | 42.5% | 38.8% | 34.3% | - | 20.8% | 21.1% | 20.9% | - |
| Effective tax rate | - | - | - | -243.1% | - | - | 44.9% | 36.2% | 31.3% | - |
| Return on assets | -7.1% | - | 1.6% | 1.6% | -2.2% | - | 1.1% | 1.3% | 2.3% | - |
| Return on equity | -11.2% | - | 2.0% | 2.2% | -3.0% | - | 1.7% | 2.1% | 3.6% | - |
| Return on invested capital | -11.2% | - | -12.2% | -5.9% | -3.6% | - | 1.7% | 2.1% | 3.5% | - |
| Liquidity | ||||||||||
| Current ratio | 1.79 | 2.26 | 2.59 | 2.36 | 2.44 | 2.50 | 2.19 | 2.13 | 2.09 | 1.99 |
| Quick ratio | 1.79 | 2.26 | 2.59 | 2.36 | 2.44 | 2.50 | 2.19 | 2.13 | 2.09 | 1.99 |
| Cash ratio | 0.46 | 0.76 | 1.00 | 1.04 | 0.73 | 0.73 | 0.60 | 0.43 | 0.26 | 0.35 |
| Leverage | ||||||||||
| Debt / Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt / Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt / EBITDA | - | - | - | - | - | - | 0.00 | 0.00 | 0.00 | - |
| Interest coverage | - | - | - | - | - | - | - | - | - | - |
| Equity multiplier | 1.58 | 1.51 | 1.31 | 1.37 | 1.39 | 1.42 | 1.52 | 1.55 | 1.58 | 1.63 |
| Liabilities / Assets | 0.47 | 0.42 | 0.26 | 0.30 | 0.30 | 0.31 | 0.34 | 0.35 | 0.36 | 0.38 |
| Efficiency | ||||||||||
| Asset turnover | 0.36 | - | 0.20 | 0.20 | 0.22 | - | 0.28 | 0.34 | 0.39 | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | 454d | - | 552d | 557d | 679d | - | 615d | 570d | 538d | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | 66.4x | 51.5x | 40.4x | - |
| P / B | 0.5x | - | 0.5x | 0.5x | 0.9x | - | 1.1x | 1.0x | 1.4x | - |
| P / S | 0.8x | - | 1.9x | 1.9x | 2.8x | - | 2.5x | 2.0x | 2.3x | - |
| EV / EBITDA | - | - | - | - | - | - | 18.4x | 18.3x | 22.9x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | -21.3% | - | -48.9% | -51.2% | -50.0% | - | -25.7% | 31.4% | 70.0% | - |
| Revenue CAGR (3y) | -12.6% | - | -6.2% | -9.8% | -6.6% | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | -33.7% | - | - | - | - | - | 16.4% | 544.0% | - | - |
| Net income growth (YoY) | -57.0% | - | 0.0% | 0.0% | - | - | 15.4% | - | - | - |
| EPS growth (YoY) | -66.7% | - | - | - | - | - | 0.0% | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | 53.8% | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -57.2% | -55.1% | -16.8% | -5.7% | -0.6% | 6.7% | 13.1% | 12.6% | 11.7% | 10.1% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$322.20M totalTransportation Services Segment$200.77M · 62.3%
Mobile Health Services Segment$121.43M · 37.7%
Geographic
$322.20M totalUS$268.25M · 83.3%
GB$53.94M · 16.7%
Peer comparison
Same SIC group: Services-Health Services
Comparing DocGo Inc. against the 5 most active filers in the same SIC group.